Cargando…
Pneumothorax as an Adverse Event in Patients with Lung Metastasis of Soft Tissue Sarcoma under Eribulin Treatment
Pneumothorax has been reported as a pazopanib-associated adverse event in patients with lung metastases of soft tissue sarcoma (STS). However, pneumothorax triggered by eribulin treatment has never been reported. We herein report two cases of spontaneous pneumothorax in patients with STS treated wit...
Autores principales: | Takada, Kohichi, Murase, Kazuyuki, Nakamura, Hajime, Hayasaka, Naotaka, Arihara, Yohei, Iyama, Satoshi, Ikeda, Hiroshi, Emori, Makoto, Sugita, Shintaro, Nakamura, Katsuyuki, Miyanishi, Koji, Kobune, Masayoshi, Kato, Junji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japanese Society of Internal Medicine
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6859383/ https://www.ncbi.nlm.nih.gov/pubmed/31243217 http://dx.doi.org/10.2169/internalmedicine.2790-19 |
Ejemplares similares
-
Combination of eribulin plus AKT inhibitor evokes synergistic cytotoxicity in soft tissue sarcoma cells
por: Hayasaka, Naotaka, et al.
Publicado: (2019) -
Small molecule CP-31398 induces reactive oxygen species-dependent apoptosis in human multiple myeloma
por: Arihara, Yohei, et al.
Publicado: (2017) -
Complete Response to Eribulin in a Patient with Unresectable Liposarcoma: A Case Report and Implications of New Biomarkers
por: Nakamura, Hajime, et al.
Publicado: (2022) -
Trastuzumab-Based Combination Chemotherapy in Patients with Human Epidermal Growth Factor Receptor-2-Positive Metastatic Carcinoma ex Pleomorphic Adenoma
por: Arihara, Yohei, et al.
Publicado: (2018) -
Exceptionally rapid response to pembrolizumab in a SMARCA4‐deficient thoracic sarcoma overexpressing PD‐L1: A case report
por: Takada, Kohichi, et al.
Publicado: (2019)